Artículos de revista

Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.

Artículos de revista /

Clin Transl Oncol. 2018 Nov;20(11):1467-1473. doi: 10.1007/s12094-018-1880-x. Epub 2018 Apr 25. Costa Rivas M, Huidobro Vence G, Fírvida Pérez JL, Campos Balea […]

Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group. Leer más »

C. Rivas M. et al.
Ver

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience.

Artículos de revista /

Transl Lung Cancer Res. 2018 Jun;7(3):404-415. doi: 10.21037/tlcr.2018.04.03. Areses Manrique MC, Mosquera Martínez J, García González J, Afonso Afonso FJ, Lázaro Quintela

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience. Leer más »

A. Manrique MC et al.
Ver

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.

Artículos de revista /

Anticancer Res. 2014 Apr;34(4):1959-66. Juan O1, Sánchez-Hernández A, Vázquez S, Casal J, Firvida JL, Aparisi F, Muñoz J, García-Sánchez J, Gironés R,

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study. Leer más »

Juan O1 et al.
Ver

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.

Artículos de revista /

Anticancer Drugs. 2014 Apr;25(4):368-74. Vázquez S1, Lázaro M, Fírvida JL, Santomé L, Afonso J, Amenedo M, Casal J; Galician Lung Cancer Group

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile. Leer más »

Vázquez S1 et al.
Ver

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Artículos de revista /

Cancer Chemother Pharmacol. 2014 Mar;73(3):451-7. Casal Rubio J1, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M,

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. Leer más »

C. Rubio J1 et al.
Ver

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.

Artículos de revista /

Expert Opin Pharmacother. 2012 Jul;13(10):1389-96. Leon L1, Vázquez S, Gracia JM, Casal J, Lazaro M, Firvida JL, Amenedo M, Santome L, Macia

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients. Leer más »

Leon L1 et al.
Ver

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.

Artículos de revista /

Cancer Chemother Pharmacol. 2009 Jul;64(2):379-84. Rubio JC1, Vázquez S, Vázquez F, Amenedo M, Fírvida JL, Mel JR, Huidobro G, Alvarez E, Lázaro

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma. Leer más »

Rubio JC1 et al.
Ver

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).

Artículos de revista /

Anticancer Drugs. 2007 Nov;18(10):1201-6. Vázquez S1, Huidobro G, Amenedo M, Fírvida JL, León L, Lázaro M, Grande C, Mel JR, Ramos M,

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02). Leer más »

Vázquez S1 et al.
Ver

Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).

Artículos de revista /

Anticancer Drugs. 2004 Jun;15(5):489-94. Vázquez S1, Grande C, Amenedo M, Fírvida JL, Lázaro M, Alonso G, Curiel T, Huidobro G, Mel JR,

Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00). Leer más »

Vázquez S1 et al.
Ver